相关实验视频

Updated: Jul 25, 2026

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening

Published on: October 26, 2017

肺癌治疗中的生物标志物

Rekha Thiruvengadam1, Carmelin Durai Singh1, Benod Kumar Kondapavuluri2

  • 1Department of Community Medicine, Saveetha Medical College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Thandalam, Chennai 602105, India.

Clinica chimica acta; international journal of clinical chemistry
|March 28, 2025
PubMed
概括

肺癌 (LC) 是癌症死亡的主要原因. 生物标志物为肺癌的早期诊断,治疗和监测提供了有希望的新途径,改善了患者的治疗结果.

关键词:
生物标志物 生物标志物诊断 诊断 诊断 诊断 诊断肺癌:肺癌是肺癌,而肺癌是肺癌.病变的发生和发病.治疗治疗疗法 治疗治疗

更多相关视频

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients07:42

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer07:59

Ultra-Fast Amplicon-Based Next-Generation Sequencing in Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...